Abstract Details

Title Increasing the Reach of Autonomic Medicine Teaching: Report on a National Course for Resident Physicians

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P5 - Poster Session 5 (5:30 PM-6:30 PM)

Poster/Presentation
Number 3-009

Objective

To describe an intensive mini-fellowship style “Residents’ Course” in autonomic medicine.

Background

Autonomic disorders are common. Exposure to autonomic medicine is limited in undergraduate and graduate medical education. Many centers do not have physicians qualified in autonomic medicine to provide clinical care or quality instruction.

Design/Methods The American Autonomic Society (AAS) established a three-day intensive course in autonomic medicine for second-year residents. Financial and logistical support was provided by a non-profit partner. Invitations to nominate trainees for the program were sent to randomly selected programs throughout the United States. Neurology, internal medicine, family practice and pediatrics training programs were included. Invitations were not sent to programs with autonomic specialists. Thirty-six residents were selected to attend. Residents were required to contribute a modest fee for participation. Transportation, housing, and room costs were otherwise provided. Six AAS faculty provided instruction. Residents completed pre, immediate post, and 6-week-post participation tests. Residents were required to provide a lecture to their home departments after the course.

Results The Residents’ Course was held January 25-28, 2023, in Clearwater, FL. The 36 resident participants represented Neurology (21), Internal Medicine (7), Pediatrics (5), and Family Medicine (3) training programs. Average pre-course test scores were 46.6%, with only 10/36 participants scoring >50%. Average immediate post-test score was 87.0%, all residents scoring 69% or higher. The 6-week post-test average was 79.8%, all residents scoring 62.5% or higher. Residents reported an average audience of 17 peers attending their lectures. This represents a potential total audience of 612 trainees receiving a lecture on autonomic medicine.

Conclusions

Our trainee-focused course in autonomic medicine resulted in significantly increased performance on a knowledge-based exam. Participants' subsequent teaching at their home institutions resulted in a multiplicative benefit and broadened geographical reach. Future courses employing this model have a high potential for impact in the field of autonomic medicine.

Authors/Disclosures
Glen A. Cook, Jr., MD, FAAN PRESENTER	Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Ratna K. Bhavaraju-Sanka, MD, FAAN (UT Health Science Center @ San Antonio)	Dr. Bhavaraju-Sanka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhavaraju-Sanka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Philip Fischer	No disclosure on file
Kelly Freeman (The Dysautonomia Project)	No disclosure on file
Elisabeth Golden, MD (University of Texas Health Science Center Tyler)	Dr. Golden has nothing to disclose.
David S. Goldstein, MD, PhD (National Institutes of Health)	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Safwan S. Jaradeh, MD, FAAN (Dept of Neurology)	Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Laura A. Pace, MD, PhD (meliora.bio)	Dr. Pace has nothing to disclose.
Sachin Paranjape	No disclosure on file
Nathaniel M. Robbins, MD (MGB)	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Howard Snapper	No disclosure on file

��ɫ��

��ɫ��